The benefits of ivabradine are independent of resting heart rate

By Riccioni Graziano  

Future Cardiology, Vol. 9, Iss. 3, 2013-05 ,pp. : 313-315

Future Medicine

Access to resources Recommend Favorite

Ivabradine: the start of a SHIFT in heart failure treatment

By Cowie Martin R  

Interventional Cardiology, Vol. 5, Iss. 1, 2013-02 ,pp. : 21-31

Future Medicine

Access to resources Recommend Favorite

Effect of Visit‐to‐Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the I_f Inhibitor Ivabradine Trial (SHIFT) Trial

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 2, 2016-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and efficacy of oral ivabradine as a heart rate-reducing agent in patients undergoing CT coronary angiography

By ADILE K K   KAPOOR A   JAIN S K   GUPTA A   KUMAR S   TEWARI S   GARG N   GOEL P K  

British Journal of Radiology, Vol. 85, Iss. 1016, 2012-08 ,pp. : 424-428

British Institute of Radiology

Access to resources Recommend Favorite

Anemia in heart failure: pathophysiologic insights and treatment options

By Terrovitis John V   Anastasiou-Nana Maria   Kaldara Elissavet   Drakos Stavros G   Nanas Serafeim N   Nanas John N  

Future Cardiology, Vol. 5, Iss. 1, 2009-01 ,pp. : 71-81

Future Medicine

Access to resources Recommend Favorite